Vision Screeners Market Size

Vision Screeners Market Analysis

The vision screeners market is expected to grow from USD 562.9 million in 2023 to USD 910.8 million by 2028, registering a CAGR of 5% during the forecast period.

• COVID-19 significantly impacted the vision screeners market since ophthalmic consultations and diagnosis were delayed due to the lockdown restrictions across the globe. For instance, according to an article published in August 2022 in MDPI journal, the lockdown during COVID-19 had a major impact on ophthalmic outpatient care in Riyadh as hundreds of appointments were canceled. This affected the course of the disease, which led to neglect of existing symptoms, a delay in detecting potentially sight-threatening complications, or even a delay in vision screening, all of which contributed to a worsening of visual outcomes.
• Thus, the utilization of vision screeners was limited during the pandemic, which impacted market growth. However, as the pandemic restrictions eased in the post-pandemic situation, the market recovery was led by an increase in vision screener device sales, new product launches, and increased eye diseases.
• The vision screener market is likely to grow during the forecast period due to the growing incidences of eye disorders, increased awareness about eye health, and technological advancements. Vision screeners are used in detecting several vision problems. They are useful for the treatment of eye-related disorders. The increasing rate of vision problems is common due to a lack of proper nutrition, irregular eye check-ups, inconsistent care, and prolonged screen time.
• For instance, as per the 2022 Vision Index report, research was conducted with myopia patients, with most respondents (81%) having trouble seeing objects at a distance and short-sightedness being the most common diagnosis for those who have had their eyesight examined by an optometrist (40%) in Australia in 2022. Increasing eye-related disorders and improved screening and diagnosis are projecting a significant impact on the market's growth. These factors lead to the widespread use of vision screeners for early indications and treatments, further boosting the market's growth.
• Furthermore, rising government initiatives and strategic activities by the key players, such as product launches, collaborations, and acquisitions, are expected to drive market expansion. For instance, according to the July 2021 update by the World Health Organization (WHO), governments adopted a new resolution at the UN general assembly pledging additional efforts to make eye care services a critical component of universal health coverage and address the growing impact of vision loss on sustainable development.
• Additionally, in August 2022, Thane-based Swaraashi Netralya introduced two state-of-the-art ophthalmic devices named "3nethra neo-HD FA" and "Mirante SLO/OCT to diagnose all ophthalmic medical conditions in children and adults in areas where medical help is the farthest away.
• Hence, due to the high prevalence of ophthalmic diseases, the rise in government initiatives to support eye care, and the increase in strategic product launches, the vision screeners market is likely to witness growth during the forecast period. However, the high cost of vision screener devices is expected to restrain market growth.